KOSDAQChemicals049830

Seung Il

₩6,480▲ 0.62%2026-11-18 close
Market Cap
₩39.7B
Turnover
₩3,115,330
Volume
488 shares
Shares out.
6.1M
PER
47.1×
PBR
0.3×
EPS
₩137
Dividend Yield
2.33%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩150 per share · Prices as of the 2026-11-18 close

01

Report overview

Seung IL: Thin Margins and Swinging Quarterly Results

Seung IL makes metal packaging in aerosol and general can formats. Annual revenue fell from KRW 158.9 billion in 2022 to KRW 141.5 billion in 2025, operating margin has stayed around 1.6%, and quarterly results in 2026 have moved between profit and loss.

  1. 1

    Annual revenue moved from KRW 158.9 billion in 2022, the largest year in the period, to KRW 141.5 billion in 2025, the smallest year in the period.

  2. 2

    Operating profit peaked at KRW 2.29 billion in 2024 and was nearly flat at KRW 2.28 billion in 2025, when operating margin was 1.6%.

  3. 3

    Quarterly results alternated: an operating loss of KRW 644 million in Q4 2025, operating profit of KRW 1.95 billion in Q2 2026, and a net loss attributable to controlling shareholders of KRW 1.7 billion in Q3 2026. Over the last four quarters, that net income totaled KRW 808 million.

  4. 4

    At the end of 2025, total equity was KRW 150.4 billion and total liabilities were KRW 35.6 billion. The debt ratio rose from 18.7% in 2024 to 23.7% in 2025.

  5. 5

    The company disclosed a corporate value-up plan on March 10, 2026, citing profit-focused operations and continued R&D. It was removed from the administrative issue list effective July 1, 2026.

02

Business structure

Seung IL makes metal packaging in two main lines: aerosol cans and general cans. Its aerosol cans for cosmetics and insecticides are supplied on an OEM basis, while its general cans, including food and industrial cans, go to customers such as CJ and GS Caltex.

In its Q1 2026 earnings commentary, the company said it held a 66% domestic aerosol share and remained first in that segment. The same commentary said low utilization and lower prices for can and valve products weighed on profitability in the quarter.

A food repackaging and sales business started in December 2024, and export reach has expanded to Southeast Asia and other continents. Plants in Cheonan and Eumseong are reported to be under construction. Metal can production requires equipment investment and customer qualification, which creates entry barriers.

Some data providers classify the stock under the KOSDAQ metals sector rather than chemicals, and its cost structure differs from large chemical makers linked to petrochemical feedstock prices. Revenue shares by aerosol and general can lines should be checked in the business segment disclosures of the annual report.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩36.7B₩500M1.3%
2025Q4₩32.4B-₩600M−2.0%
2026Q1₩35.3B₩400M1.2%
2026Q2₩41.4B₩2B4.7%
2026Q3₩35.9B₩700M1.8%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩158.9B₩1.3B₩1.3B0.8%0.9%21.5%
2023₩141.9B₩600M₩400M0.4%0.3%19.0%
2024₩144.4B₩2.3B₩3.7B1.6%2.5%18.7%
2025₩141.5B₩2.3B₩2.5B1.6%1.7%23.7%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-16

04

Earnings analysis

On the audited annual basis, revenue fell from KRW 158.9 billion in 2022 to KRW 141.9 billion in 2023, a 10.7% decline, rose 1.8% to KRW 144.4 billion in 2024, and then fell 2.0% to KRW 141.5 billion in 2025.

Operating profit was KRW 1.29 billion in 2022, KRW 598 million in 2023 after a 53.5% drop, KRW 2.29 billion in 2024 after a 282.3% gain, and KRW 2.28 billion in 2025, down 0.4%. Operating margin was 0.8%, 0.4%, 1.6% and 1.6% over 2022 to 2025, so profit is thin relative to sales.

For 2024, the company attributed the operating profit increase to higher sales from a strong dollar and lower manufacturing costs from reduced raw material expenses. Net income attributable to controlling shareholders peaked at KRW 3.66 billion in 2024 and fell 31.3% to KRW 2.52 billion in 2025.

Net income including non-controlling interests was also KRW 2.52 billion in 2025. Operating cash flow was KRW 2.29 billion in 2022, KRW 8.25 billion in 2023, KRW 15.8 billion in 2024 and KRW 10.2 billion in 2025.

On a quarterly basis, Q3 2025 revenue was KRW 36.7 billion with operating profit of KRW 464 million and controlling net income of KRW 674 million.

Q4 2025 revenue was KRW 32.4 billion, down 11.5% from the prior quarter, with an operating loss of KRW 644 million and a net loss attributable to controlling shareholders of KRW 546 million.

Q1 2026 revenue was KRW 35.3 billion with operating profit of KRW 425 million and controlling net income of KRW 1.2 billion, a return to profit. Q2 2026 revenue was KRW 41.4 billion, operating profit was KRW 1.95 billion, up 359.2% from the prior quarter, and controlling net income was KRW 1.86 billion.

Q3 2026 revenue was KRW 35.9 billion, down 13.3% from the prior quarter and 2.1% from a year earlier, with operating profit of KRW 663 million, down 66.0% from the prior quarter and up 42.9% from a year earlier.

The company posted a net loss attributable to controlling shareholders of KRW 1.7 billion in Q3 2026, a swing to loss from a year earlier. The gap between positive operating profit and a controlling-shareholder loss in Q3 2026 is a point to check against non-operating items in the quarterly report.

05

Industry analysis

Demand for Seung IL comes from aerosol containers for cosmetics and insecticides and from food and industrial general cans. Aerosol volumes depend on customers' production plans and cosmetic OEM orders, so utilization moves with those schedules.

In its Q1 2026 commentary, the company cited low utilization as a cause of weaker profitability. In practice, filling production capacity matters as much as the underlying can demand. General cans depend on food consumption and industrial output.

Raw materials such as steel and aluminum, along with valve components, feed into cost. In Q1 2026, lower can and valve prices reduced both revenue and operating profit, according to the company. The company claims a leading share of the domestic aerosol can market, which gives it a solid position.

In metal packaging, competitiveness rests on plant scale, customer qualification and delivery capability. With plants being built in Cheonan and Eumseong, the ability to fill new capacity will be a key variable for its position within the industry.

Export expansion toward Southeast Asia and other continents is the stated direction, and its results should be tracked in future revenue mix.

06

Outlook

In its corporate value-up plan disclosed on March 10, 2026, the company set out a direction of raising earnings power through profit-focused operations and sustaining technology leadership through continued R&D.

The same plan showed a payout ratio of 35.23% for the prior fiscal year, and the board approved the dividend with an unqualified audit opinion and the consent of all audit committee members. The stock was removed from the administrative issue list effective July 1, 2026, which marks a shift toward normal trading.

Plants under construction in Cheonan and Eumseong expand production capacity, and their completion and start-up will bring fixed-cost and utilization effects that should be reviewed together.

The food repackaging business began sales in December 2024, and export reach is expanding to Southeast Asia and other continents. How much these businesses contribute to sales and profit has not been quantified in disclosed material. The company's direction is stated qualitatively without specific numerical targets.

Q4 2026 is the final quarter of fiscal 2026, so full-year results will be confirmed in the 2026 annual report. That report will show full-year revenue, operating profit, net income attributable to controlling shareholders and the dividend decision.

Whether quarterly results return to losses as in Q4 2025, and what drove the Q3 2026 net loss, are also points to track.

07

Valuation

PER
47.1×
PBR
0.3×
ROE
0.5%
EPS
₩137
BPS
₩25,546
Dividend per share
₩150

The share price sits well below book value per share, close to a discount to net asset value. Earnings-based multiples are high, because net income attributable to controlling shareholders over the last four quarters totaled KRW 808 million, small relative to the equity value.

The high earnings multiple reflects a small earnings base rather than a low price. The 2025 payout ratio was 35.23%, and dividends depend on the scale of earnings. Operating margin stayed between 0.4% and 1.6% over 2022 to 2025, so the multiple will move with how far earnings recover.

Over several years, earnings dropped sharply in 2023, recovered in 2024, and were broadly held in 2025. In 2026, operating profit jumped in Q2 but the company then posted a controlling-shareholder net loss in Q3, so the quarterly trend is not stable. Because multiples react strongly to earnings changes, they should be read alongside quarterly results.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-16

08

Bull factors

Leading domestic aerosol position

In its Q1 2026 commentary, the company said its domestic aerosol share was 66% and that it remains first in the segment. Its OEM customer base for cosmetics and insecticides reflects customer qualification barriers.

The utilization and pricing factors cited for weaker Q1 profitability are the levers that would change profitability metrics.

Operating cash generation

Operating cash flow rose from KRW 2.29 billion in 2022 to KRW 8.25 billion in 2023 and KRW 15.8 billion in 2024, and was KRW 10.2 billion in 2025. Against operating profit of KRW 2.28 billion in 2025, cash generation was larger than reported profit that year. Its composition should be checked in the annual report.

Q2 2026 earnings recovery and balance sheet capacity

Q2 2026 operating profit was KRW 1.95 billion, up 359.2% from the prior quarter, following a return to profit in Q1. At the end of 2025, total equity was KRW 150.4 billion against total liabilities of KRW 35.6 billion. The debt ratio rose to 23.7% in 2025, but equity remains larger than liabilities.

09

Bear factors

Shrinking revenue base

Annual revenue declined from KRW 158.9 billion in 2022 to KRW 141.5 billion in 2025, the smallest year in the period. Q3 2026 revenue was down 2.1% from a year earlier, so a recovery in top-line growth has not yet shown up. Lower revenue can increase the burden of fixed costs and thin margins further.

Thin margins and loss quarters

Operating margin stayed low, between 0.4% in 2023 and 1.6% in 2025. The company posted an operating loss of KRW 644 million in Q4 2025 and a controlling-shareholder net loss of KRW 1.7 billion in Q3 2026.

Net income attributable to controlling shareholders totaled KRW 808 million over the last four quarters, leaving little earnings cushion.

Utilization and pricing pressure

In its Q1 2026 commentary, the company cited low utilization and lower can and valve prices as causes of weaker profitability. On a separate-financials basis, Q1 2026 operating profit fell 58.3% from a year earlier.

If pricing and utilization stay weak at the same time, the benefit from new capacity could arrive later than planned.

10

Risk factors

Raw material and pricing risk

Raw material and component prices drive cost. In 2024, lower raw material expenses supported operating profit. In Q1 2026, lower can and valve prices reduced both revenue and profit. The company has cited exchange rates as a factor in sales, so results can move with currency direction.

Capacity investment and utilization risk

The plants under construction in Cheonan and Eumseong expand capacity. If new lines come online while utilization is low, fixed-cost burden could rise. The debt ratio increased to 23.7% in 2025 from 18.7% in 2024, and it could move further depending on investment scale.

Trading and listing-status risk

The stock was placed on the administrative issue list due to poor trading performance and removed effective July 1, 2026. Such a history can affect trading and investor sentiment. If quarterly losses recur, trading conditions and listing requirements may need to be reviewed again.

11

What to watch next

  1. December 31, 2026

    Fiscal 2026 ends. Q4 results will be consolidated into the full year, and whether an operating loss recurs as in Q4 2025 is the key question.

  2. March 31, 2027 (statutory filing deadline)

    Filing of the 2026 annual report. It will show full-year revenue, operating profit, net income attributable to controlling shareholders, the dividend decision and the debt ratio trend.

  3. May 15, 2027 (statutory filing deadline)

    Filing of the Q1 2027 quarterly report. It will show whether utilization and cost trends have improved from Q1 2026.

  4. When the completion schedule is disclosed (date not yet set)

    Completion and start-up of the Cheonan and Eumseong plants. Their effect on utilization and fixed costs should be read together.

12

Overall view

Seung IL holds a leading position with a 66% domestic share in aerosol cans, and its operating cash flow has risen sharply since 2022. Total equity of KRW 150.4 billion exceeding total liabilities of KRW 35.6 billion is a stabilizing factor.

Revenue, however, fell from KRW 158.9 billion in 2022 to KRW 141.5 billion in 2025, and operating margin has stayed between 0.4% and 1.6%, leaving a thin profit cushion.

Quarterly results have been uneven, with an operating loss in Q4 2025, operating profit of KRW 1.95 billion in Q2 2026 and a controlling-shareholder net loss of KRW 1.7 billion in Q3 2026. The share price sits well below book value per share, while earnings multiples are high because the earnings base is small.

Strengths include market position, cash generation and the Q2 2026 profit recovery. Weaknesses include the revenue decline, thin margins, and utilization and pricing pressure.

The next checkpoint is the 2026 annual report, where full-year operating margin, the dividend decision and the performance of the Cheonan and Eumseong plants will be the key items.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. comp.fnguide.com
  2. comp.wisereport.co.kr
  3. kpinfo.kr
  4. edaily.co.kr
  5. akground.com
  6. edaily.co.kr
  7. edaily.co.kr
  8. m.news.nate.com
  9. edaily.co.kr
  10. topstarnews.net
  11. edaily.co.kr
  12. edaily.co.kr
  13. edaily.co.kr
  14. samsung.com
  15. apple.com
  16. specialtimes.co.kr
  17. digitaltoday.co.kr
  18. edaily.co.kr

Report written 2026-11-16 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis